Mayo Clinic Built a Medical Machine Around One Stubborn Rule

The most revealing thing about Mayo Clinic is not its rankings, its marble buildings or even the steady procession of difficult cases arriving in Rochester, Minnesota. It is a sentence. “The needs of the patient come first” is short enough to fit on a badge and demanding enough to reorganize an institution. At Mayo, the phrase became an operating constraint: specialists share a record, physicians are salaried, and the clinical team is assembled around the case rather than asking the case to tour a maze of disconnected practices.

That design is the product. Mayo Clinic is legally a nonprofit and publicly understood as a hospital, but neither label fully captures it. It is an academic medical center, a large multi-specialty group practice, a medical school, a research enterprise, a reference laboratory, a publisher, a network for independent hospitals and, increasingly, a data and AI platform. Each piece feeds the others. An unusual patient produces a clinical question. The question becomes a study. The finding enters training and practice. The next patient gets an answer faster.

The scale is substantial: roughly 1.3 million patients from more than 130 countries visit Mayo campuses each year. More than 80,000 people work across the organization. In 2024, revenue reached about $19.8 billion. Yet the interesting part is less the size than the architecture. Mayo has spent a century turning expert judgment into a repeatable system.

A tornado, a handshake and a group practice

Mayo’s origin story has the narrative economy of a parable. William Worrall Mayo opened a medical practice in Rochester in 1864. His sons, William James and Charles Horace, joined him in the 1880s. After a tornado devastated the town in 1883, the Mayo family worked alongside the Sisters of Saint Francis. Mother Alfred Moes proposed a permanent hospital: the sisters would raise the money and serve as nurses; the Mayos would provide medical care. Saint Marys Hospital opened in 1889 with 27 beds.

The practice expanded by inviting doctors with complementary specialties into the group. That was unusual in an era of proprietary solo practice. The brothers traveled to learn new techniques and let visiting physicians watch them work. Those informal sessions were called the “Mayos’ clinic.” The nickname proved more efficient than the partnership’s magnificent mouthful: “The Doctors Mayo, Stinchfield, Graham, Plummer, Judd and Balfour.” Mayo Clinic became the official name in 1914.

Then came the choice that fixed the institution’s direction. In 1919, Will and Charlie Mayo and their wives donated the practice, its assets and most of their savings to establish a nonprofit. They removed the family as owners of the machine they had built. Income could be recycled into facilities, research and education. A successful private practice became a long-term public trust.

“The needs of the patient come first.”Mayo Clinic’s primary value

Three shields, one feedback loop

Mayo’s logo contains three shields for clinical practice, research and education, with practice at the center. It is a tidy visual explanation of the business. Patient care generates most of the revenue and supplies the clinical problems. Research tests possible answers. Education distributes the knowledge through medical school, graduate programs, residencies, fellowships and allied-health training.

The research operation reported $1.32 billion in support in 2025, 9,506 active human studies and 10,835 peer-reviewed publications. Those numbers describe a discovery engine attached directly to clinical care. Physicians and scientists work near each other, and a patient with an uncommon condition can become the reason a new assay, imaging method or treatment protocol is developed.

For patients, the practical benefit is coordination. Complex disease rarely respects departmental boundaries. A cancer may require pathology, radiology, surgery, oncology, genetics and rehabilitation. The Mayo model tries to compress those handoffs into one team and one itinerary. It cannot erase uncertainty, but it can reduce the administrative friction surrounding it.

How expertise leaves Rochester

Not every customer is a patient walking through a Mayo campus. Mayo Clinic Laboratories turns specialist knowledge into diagnostic products. In 2025, the laboratory business listed more than 4,300 orderable tests, launched more than 100 new ones and performed about 28 million tests. The specimen travels; the patient can stay close to home. For rare and complex conditions, that logistics network is part of the clinical service.

The Mayo Clinic Care Network follows a different route. More than 45 independent hospitals pay for access to Mayo knowledge and specialists without being acquired. Their doctors can request asynchronous eConsults, use standardized guidance in AskMayoExpert, join case conferences and access education. Patients get additional expertise through a local clinician, generally at no extra cost for the network consultation. The hospital keeps its ownership and, when appropriate, its patient.

Mayo also sells or distributes knowledge through continuing medical education, books, professional journals, consumer health content, consulting and content licensing. Insurers, apps and health systems can place physician-reviewed Mayo information inside their own products. It is a less dramatic business than transplant surgery, but it solves the same scaling problem: how to move judgment farther than the buildings.

The clinic becomes an AI proving ground

Mayo Clinic Platform is the most ambitious extension of this idea. It serves providers, researchers, biopharma companies, device makers and health-tech startups that need de-identified clinical data, expert input, model validation and a route into real workflows. The platform’s promise is end to end: discover a signal, build a product, test it, deploy it and monitor how it behaves.

The raw material is unusually deep clinical context. Mayo and Aignostics built Atlas, a pathology foundation model trained on more than 1.2 million whole-slide images. Mayo has deployed NVIDIA Blackwell infrastructure to accelerate generative AI and digital pathology work. With Microsoft Research it is exploring models that combine chest X-rays and text; with Cerebras Systems, genomic foundation models. In 2026, Merck joined an R&D collaboration aimed at AI-enabled drug discovery and precision medicine.

The hard part of healthcare AI is rarely a flashy demonstration. It is representative data, clinical validation, privacy, regulation, integration and whether a busy clinician will use the tool correctly. Mayo’s “Data Behind Glass” approach keeps de-identified data under the contributing organization’s control while allowing approved analysis across a federated network. Partners including Mercy, Seoul National University Hospital and Sheba Medical Center broaden the populations available for research.

This is where Mayo differs from a general technology vendor. Its advantage is not merely compute or model architecture, which partners can provide. It is the combination of difficult cases, specialist interpretation, longitudinal data and a live care environment. The clinic can tell a developer that a statistically impressive output is useless at 7:20 on a Monday morning because it arrives in the wrong screen.

A nonprofit in several competitive arenas

Mayo competes with Cleveland Clinic, Johns Hopkins, Mass General Brigham and other academic centers for complex cases, clinicians, researchers and donations. Regional systems compete for everyday care. Labcorp, Quest and specialist reference labs compete in diagnostics. Health-data networks and clinical AI companies compete for industry partnerships. Medical publishers and consumer health sites compete for attention.

Its defense is the integration across those categories. A laboratory can offer volume. A university can offer research. A software company can offer infrastructure. Another hospital can offer excellent care. Mayo’s proposition is that the pieces work better when they share incentives and institutional memory. The reputation helps attract difficult cases; difficult cases sharpen expertise; expertise supports research, education and products; those activities reinforce the reputation.

That loop has limits. Destination care can be expensive and difficult to access. A vast institution can create its own bureaucracy. Hospital rankings are imperfect proxies for an individual patient’s outcome. AI partnerships produce announcements long before they produce routine clinical benefits. Mayo’s task is to scale what is distinctive without turning trust into a licensing sticker or data into a product detached from consent.

Mayo’s real export is not a building. It is a way of arranging expertise around a question.

Keep the rule, change the delivery mechanism

The modern Mayo Clinic is trying to make a place-based institution behave like a distributed network. Its Orchestrate program gives drug and device companies one route into data, biospecimens, clinical expertise, validation and deployment. Its expanded work with Mercy makes research populations more diverse. Digital pathology turns a slide archive into infrastructure for models that may assist diagnosis and reduce repetitive work.

The opportunity is not to replace the group practice with software. It is to encode parts of the group practice into tools: the right specialist consulted sooner, the rare pattern recognized, the unnecessary referral avoided, the treatment matched more precisely and the local doctor better supported. If that works, Mayo can help patients it never physically sees.

The institution began with a physician, his sons, a group of Franciscan sisters and a town in crisis. Its tools have changed from a mortgaged microscope to supercomputers, but the organizational question is familiar: can different kinds of expertise cooperate around the person who needs an answer? Mayo Clinic has spent 160 years making that question operational. The next phase is to see how far the answer can travel.